Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malvina Seradj

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|February 24, 2024
Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor propertiesFériel Bekkat, Malvina Seradj, Renée Lengagne, et al.
Cancer Immunology Research|January 15, 2026
Conditional IL4I1 inactivation triggers tumor-associated macrophage reprogramming and CD8+ T-cell reactivation to control melanoma progressionMalvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|February 24, 2024
Upregulation of IL4-induced gene 1 enzyme by B2 cells during melanoma progression impairs their antitumor propertiesFériel Bekkat, Malvina Seradj, Renée Lengagne, et al.
Cancer Immunology Research|January 15, 2026
Conditional IL4I1 inactivation triggers tumor-associated macrophage reprogramming and CD8+ T-cell reactivation to control melanoma progressionMalvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, et al.
Pageof 1